Pharmaceutical News

RSS

New UTMB study finds no association between testosterone therapy and blood clots in veins

A new study from The University of Texas Medical Branch at Galveston of more than 30,000 commercially insured men is the first large comparative analysis to show that there is no link between testosterone therapy and blood clots in veins. The study found that middle-aged and older men who receive testosterone therapy are not at increased risk of this illness.

21 Jul 2015

Antibiotics may increase risk of juvenile arthritis

Taking antibiotics may increase the risk that a child will develop juvenile arthritis, according to a study from Rutgers University, University of Pennsylvania and Nemours A.I. duPont Hospital for Children published today in Pediatrics.

21 Jul 2015

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.

20 Jul 2015

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Delcath Systems, Inc., a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announced today that the U.S. Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma.

20 Jul 2015

ZEVALIN drug now available to non-Hodgkin's lymphoma patients in Hong Kong

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announces that ZEVALIN is now available at hospitals in Hong Kong to patients with indicated non-Hodgkin's lymphoma (NHL), including at Hong Kong Sanatorium & Hospital.

20 Jul 2015

Scientists find potent agent that thwarts drug resistance in malaria parasite

Scientists have made an important breakthrough in the fight against malaria, identifying a potent agent that thwarts drug resistance in the parasite that causes the disease.

20 Jul 2015

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).

17 Jul 2015

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).

17 Jul 2015

Researchers demonstrate new multispectral microscope to speed up drug discovery

A new multispectral microscope, one capable of processing nearly 17 billion pixels representing 13 individual color channels in a single image, has been successfully demonstrated by a team of researchers from the United States and Australia. This is the largest such microscopic image ever created.

17 Jul 2015

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential use of an existing chemotherapeutic cancer drug.

17 Jul 2015

Alternative approach to treat fatal blood clots found to be more effective in patients

Potentially fatal blood clots account for thousands of emergency room visits each year and often those patients are admitted to the hospital, treated with an injectable anticoagulant and monitored for a few days.

17 Jul 2015

$New study shows cannabinoid cannabidiol can help heal bone fractures$

New study shows cannabinoid cannabidiol can help heal bone fractures

Cannabis -- marijuana, hashish -- was used as a go-to medical remedy by societies around the world for centuries. But the therapeutic use of marijuana was banned in most countries in the 1930s and '40s due to a growing awareness of the dangers of addiction. The significant medical benefits of marijuana in alleviating symptoms of such diseases as Parkinson's, cancer, and multiple sclerosis have only recently been reinvestigated.

17 Jul 2015

New study shows that lithium chloride could be used to treat arthritis

Lithium chloride which is used as a mood stabiliser in the treatment of mental health problems, mainly bipolar disorder, could be used to treat arthritis according to a new study.

16 Jul 2015

GSK starts shipping FLUARIX QUADRIVALENT (Influenza Vaccine) to US healthcare providers

GSK announced today it has begun shipping FLUARIX QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research.

16 Jul 2015

Majority of Canadians support inclusion of private drug plans in pan-Canadian pharmacare program

While a strong majority of Canadians support the concept of a pan-Canadian pharmacare program, they don't necessarily want it to replace their existing private prescription drug plans according to a national survey conducted as part of the Canadian Pharmacists Association's Pharmacare 2.0 Initiative.

16 Jul 2015

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

US-Australian drug discovery company, Novogen Limited, today announced that it has received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma.

16 Jul 2015

Discovery brings hope for people suffering from Parkinson's disease

Scientists from Singapore's Nanyang Technological University and McLean Hospital and Harvard Medical School in the United States have found that existing anti-malaria drugs could be a potential treatment for Parkinson's disease.

16 Jul 2015

UW researchers help develop new compound to combat malaria

An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.

16 Jul 2015

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

SLU pain researcher Daniela Salvemini has been awarded the NIH's Cutting-Edge Basic Research Award (CEBRA) to solve an alarming problem: pain killers that are capable of quelling terrible pain also carry debilitating side effects and significant risk of addiction.

16 Jul 2015

New drug DSM265 shows potential to cure, prevent malaria

Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.

16 Jul 2015

Pharmaceutical News

New UTMB study finds no association between testosterone therapy and blood clots in veins

Antibiotics may increase risk of juvenile arthritis

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

Melphalan granted FDA Orphan Drug Designation for treatment of cholangiocarcinoma

ZEVALIN drug now available to non-Hodgkin's lymphoma patients in Hong Kong

Scientists find potent agent that thwarts drug resistance in malaria parasite

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

Researchers demonstrate new multispectral microscope to speed up drug discovery

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Alternative approach to treat fatal blood clots found to be more effective in patients

New study shows cannabinoid cannabidiol can help heal bone fractures

New study shows that lithium chloride could be used to treat arthritis

GSK starts shipping FLUARIX QUADRIVALENT (Influenza Vaccine) to US healthcare providers

Majority of Canadians support inclusion of private drug plans in pan-Canadian pharmacare program

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

Discovery brings hope for people suffering from Parkinson's disease

UW researchers help develop new compound to combat malaria

SLU researcher awarded NIH's Cutting-Edge Basic Research Award to solve pain-killer problem

New drug DSM265 shows potential to cure, prevent malaria

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News